Related Experiment Video
Updated: Aug 23, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer
1Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, People's Republic of China.
Abstract:
Gastric cancer remains one of the cancers with the highest mortality in the world; therefore, it is very important to investigate its pathogenesis to improve the prognosis of gastric cancer patients. Recently, noncoding RNAs have become a research hotspot in the field of oncology. These RNA molecules play complex roles in the regulation of tumor cells, immune cells, and the tumor microenvironment. Therefore, studying their ability to regulate the gastric cancer immune microenvironment will provide us with a better perspective to understand their potential role in anticancer therapy. In this review, we discuss the regulatory effects of several common noncoding RNAs on the immune microenvironment of gastric cancer and their prospects in anticancer therapy to provide some novel insight into the identification of valuable diagnostic markers and improving the prognosis of gastric cancer patients.
Insights
Noncoding RNAs significantly impact gastric cancer
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Gastric cancer has high mortality rates globally.
- Noncoding RNAs are crucial regulators in cancer.
- Understanding their role in the gastric cancer immune microenvironment is vital.
Purpose of the Study:
- To review the regulatory effects of noncoding RNAs on the gastric cancer immune microenvironment.
- To explore the therapeutic prospects of noncoding RNAs in gastric cancer treatment.
Main Methods:
- Literature review of noncoding RNAs in gastric cancer immunology.
- Analysis of regulatory mechanisms and therapeutic potential.
Main Results:
- Noncoding RNAs modulate tumor cells, immune cells, and the tumor microenvironment in gastric cancer.
- These molecules offer potential for novel diagnostic markers and therapeutic strategies.
Conclusions:
- Noncoding RNAs play complex roles in the gastric cancer immune landscape.
- Targeting noncoding RNAs presents a promising avenue for improving gastric cancer patient prognosis and anticancer therapy.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Experimental RNAi
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

